Li Liu

Li Liu

Auto-generated profile, based on publicly available information

Li Liu

Institute of Basic Medical Sciences, Xi’an Medical University, Xi’an 710021, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RJRajiv Kumar Jha
Rajiv Kumar Jha
YMYangmin Ma
Yangmin Ma
ZGZhiyu Guo
Zhiyu Guo
LLLi Liu
Li Liu
YYYaru Yang
Yaru Yang
WYWenjuan Yang
Wenjuan Yang
Breast cancer has become a worldwide threat, and chemotherapy remains a routine treatment. Patients are forced to receive continuous chemotherapy and suffer from severe side effects and poor prognosis. Natural alkaloids, such as piperine (PP) and piperlongumine (PL), are expected to become a new strategy against breast cancer due to their reliable anticancer potential. In the present study, cell viability, flow cytometry, and Western blot assays were performed to evaluate the suppression effect of PP and PL, alone or in combination. Data showed that PP and PL synergistically inhibited breast cancer cells proliferation at lower doses, while only weak killing effect was observed in normal breast cells, indicating a good selectivity. Furthermore, apoptosis and STAT3 signaling pathway-associated protein levels were analyzed. We demonstrated that PP and PL in combination inhibit STAT3 phosphorylation and regulate downstream molecules to induce apoptosis in breast cancer cells. Taken together, these results revealed that inactivation of STAT3 was a novel mechanism with treatment of PP and PL, suggesting that combination application of natural alkaloids may be a potential strategy for prevention and therapy of breast cancer.